Please login to the form below

Not currently logged in


This page shows the latest Aurobindo news and features for those working in and with pharma, biotech and healthcare.

Novartis sells off part of Sandoz portfolio

Novartis sells off part of Sandoz portfolio

In return Aurobindo is set to receive approximately 300 products, as well as additional development projects and Sandoz’ dermatology development centre. ... Around 750 employees will also transfer over to Aurobindo, and Sandoz’ US president Carol

Latest news

More from news
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    radioligands and CAR‐T for cancer. $2.1B. Sale. Aurobindo. NovartIs sold part of Sandoz’s US generics. ... Roche. Oral solid generics and dermatology business. Collaboration. $1.375B. Sandoz/ Aurobindo.

  • Deal Watch January 2017 Deal Watch January 2017

    140. Generis. Aurobindo. Company acquisition. Generic products. 135. Maverick. Takeda. Option to acquire.

  • Pharma deals in July 2015 Pharma deals in July 2015

    In early 2014 Actavis sold most of its European generics business to Aurobindo and in March 2015 completed the acquisition of Allergan.

  • Pharma deals during January 2014 Pharma deals during January 2014

    Slimming the business down a little, Actavis sold some of its generic products in France, Italy, Spain,  Portugal, Belgium, Germany and the Netherlands to Aurobindo for $41m.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Ramprasad Reddy to chair Aurobindo’s US business

    In addition, Aurobindo's board also approved that Ramprasad Reddy relinquish his executive responsibilities as full-time director of the company, although he will continue as non-exectuive director. ... Ramprasad Reddy also has roles at several other

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...